| Total metastatica N = 2627 | <70 yearsa N = 359 | ≥70 yearsa N = 2268 | |||
Chemotherapy | HR | 95% CI | HR | 95% CI | HR | 95% CI |
Treated | ref |
| ref |
| ref |
|
Not treated | 1.095 | 1.00 - 1.20 | 1.455 | 1.08 - 1.96 | 1.166 | 1.06 - 1.29 |
Age at diagnosis |
|
|
|
|
|
|
66 - 70 | ref | ref |
|
|
|
|
71 - 75 | 1.095 | 0.95 - 1.26 |
|
|
|
|
76 - 80 | 1.333 | 1.16 - 1.54 |
|
|
|
|
>80 | 1.707 | 1.48 - 1.96 |
|
|
|
|
Race/ethnicity |
|
|
|
|
|
|
White | ref |
| ref |
| ref |
|
Black | 0.863 | 0.76 - 0.98 | 0.731 | 0.52 - 1.02 | 0.851 | 0.74 - 0.98 |
Others | 0.795 | 0.64 - 0.99 | 0.760 | 0.36 - 1.60 | 0.781 | 0.62 - 0.98 |
Stage at initial diagnosis |
|
|
|
|
|
|
Stage I | ref |
| ref |
| ref |
|
Stage II | 1.196 | 1.05 - 1.36 | 1.193 | 0.76 - 1.87 | 1.208 | 1.06 - 1.38 |
Stage III | 1.424 | 1.22 - 1.66 | 1.825 | 1.10 - 3.02 | 1.455 | 1.24 - 1.71 |
Stage IV | 1.609 | 1.40 - 1.85 | 2.170 | 1.38 - 3.42 | 1.564 | 1.35 - 1.82 |
PPI |
|
|
|
|
|
|
No | ref |
| ref |
| ref |
|
Yes | 1.180 | 1.03 - 1.35 | 1.122 | 0.71 - 1.79 | 1.215 | 1.05 - 1.41 |
NCI comorbidity score |
|
|
|
|
|
|
0 | ref |
| ref |
| ref |
|
1 | 1.236 | 1.11 - 1.38 | 0.773 | 0.55 - 1.09 | 1.304 | 1.16 - 1.46 |
2 | 1.046 | 0.90 - 1.22 | 1.268 | 0.74 - 2.17 | 1.055 | 0.90 - 1.24 |
≥3 | 1.424 | 1.21 - 1.67 | 1.907 | 1.24 - 2.94 | 1.339 | 1.12 - 1.60 |
Radiotherapy |
|
|
|
|
|
|
No | ref |
| ref |
| ref |
|
Yes | 0.809 | 0.74 - 0.89 | 0.972 | 0.73 - 1.29 | 0.763 | 0.69 - 0.84 |
Breast cancer surgery |
|
|
|
|
|
|
No | ref |
| ref |
| ref |
|
Yes | 0.618 | 0.55 - 0.70 | 0.438 | 0.32 - 0.61 | 0.663 | 0.58 - 0.76 |